Ingalls & Snyder LLC’s Intermolecular, Inc. IMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-16,500
Closed -$19K 444
2019
Q2
$19K Hold
16,500
﹤0.01% 421
2019
Q1
$19K Hold
16,500
﹤0.01% 411
2018
Q4
$17K Sell
16,500
-10,000
-38% -$10K ﹤0.01% 407
2018
Q3
$31K Hold
26,500
﹤0.01% 442
2018
Q2
$44K Hold
26,500
﹤0.01% 401
2018
Q1
$35K Buy
26,500
+9,500
+56% +$13.5K ﹤0.01% 395
2017
Q4
$23K Buy
17,000
+7,000
+70% +$8.43K ﹤0.01% 392
2017
Q3
$10K Buy
+10,000
New +$9.42K ﹤0.01% 361
2016
Q3
Sell
-10,000
Closed -$15K 434
2016
Q2
$15K Hold
10,000
﹤0.01% 422
2016
Q1
$25K Sell
10,000
-10,000
-50% -$22.5K ﹤0.01% 355
2015
Q4
$46K Hold
20,000
﹤0.01% 363
2015
Q3
$37K Hold
20,000
﹤0.01% 357
2015
Q2
$39K Hold
20,000
﹤0.01% 369
2015
Q1
$32K Buy
+20,000
New +$34.1K ﹤0.01% 375

Ingalls & Snyder LLC's IMI Position: Q3 2019 in Review

Ingalls & Snyder LLC sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 16,500 shares — an estimated $19K sold.

Ingalls & Snyder LLC first reported a position in IMI in Q1 2015 and held it in 14 quarters. The position peaked at $46K in Q4 2015. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.

  • Ingalls & Snyder LLC reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 16,500 Intermolecular, Inc. shares in Q3 2019, an estimated $19K.
  • Ingalls & Snyder LLC first reported a position in Intermolecular, Inc. in Q1 2015 and held it in 14 quarters.
  • Ingalls & Snyder LLC's Intermolecular, Inc. position peaked at $46K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.

Based on Ingalls & Snyder LLC's 13F filing for Q3 2019, filed 16 Oct 2019.